Cargando…
Clinical and Biological Markers in Hypereosinophilic Syndromes
Hypereosinophilic syndromes (HES) are rare, heterogeneous syndromes characterized by markedly elevated eosinophil counts in the blood and/or tissue and evidence of eosinophil-associated pathology. Although parasitic infections, drug hypersensitivity, and other disorders of defined etiology can prese...
Autores principales: | Khoury, Paneez, Makiya, Michelle, Klion, Amy D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743906/ https://www.ncbi.nlm.nih.gov/pubmed/29312946 http://dx.doi.org/10.3389/fmed.2017.00240 |
Ejemplares similares
-
COVID-19 infection in hypereosinophilic syndrome: A survey-based analysis
por: Espinoza, David F., et al.
Publicado: (2022) -
Genomics of PDGFR-rearranged hypereosinophilic syndrome
por: Rheinbay, Esther, et al.
Publicado: (2023) -
PB2229: A PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF BENRALIZUMAB IN PATIENTS WITH HYPEREOSINOPHILIC SYNDROME
por: Ogbogu, Princess, et al.
Publicado: (2023) -
Transcript- and protein-level analyses of the response of human eosinophils to glucocorticoids
por: Gadkari, Manasi, et al.
Publicado: (2018) -
Clinical analysis of hypereosinophilic syndrome first presenting with asthma-like symptoms
por: Wei, Xuan, et al.
Publicado: (2021)